PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34875574-11 2022 FM IL-1beta secretion was inhibited by allopurinol, which blocks uric acid production, for LPS and PGN, and to a lesser degree, MDP. Allopurinol 39-50 interleukin 1 alpha Homo sapiens 3-11 1325990-5 1992 IL-1 released during reoxygenation was newly synthesized, and its production was triggered by the generation of oxygen free radicals, as it could be blocked by the addition of either allopurinol or free radical scavengers to cultures and could be stimulated in part by low concentrations of hydrogen peroxide or xanthine/xanthine oxidase. Allopurinol 183-194 interleukin 1 alpha Homo sapiens 0-4 31705795-0 2020 Allopurinol inhibits excess glucose-induced trophoblast IL-1beta and ROS production. Allopurinol 0-11 interleukin 1 alpha Homo sapiens 56-64 33456597-9 2020 Addition of synbiotic to allopurinol leads to a blood uric acid lowering (18.7% vs. 13.3%, p <0.01), CRP reduction (75% vs. 26.3%, p <0.01) as well as decrease of cytokines level: IL-1beta, IL-6, IL-8, IL-10 and TNFalpha (all p <0.001). Allopurinol 25-36 interleukin 1 alpha Homo sapiens 180-188 31705795-6 2020 Under excess glucose conditions, allopurinol significantly inhibited trophoblast secretion of inflammatory IL-1beta; caspase-1 activity; IL-8; RANTES; and GRO-alpha. Allopurinol 33-44 interleukin 1 alpha Homo sapiens 107-115 31705795-10 2020 Together, our findings indicate that the xanthine oxidase inhibitor allopurinol inhibited excess glucose-induced trophoblast IL-1beta secretion. Allopurinol 68-79 interleukin 1 alpha Homo sapiens 125-133 31705795-11 2020 Additionally, through its inhibition of both IL-1beta and ROS production by the trophoblast, allopurinol reduced the additional pro-inflammatory and anti-angiogenic responses to excess glucose. Allopurinol 93-104 interleukin 1 alpha Homo sapiens 45-53 24758886-8 2014 Recently, reports for four trials described the efficacy of canakinumab and rilonacept, two IL-1 inhibitors, for preventing flares during the initiation of allopurinol therapy. Allopurinol 156-167 interleukin 1 alpha Homo sapiens 92-96 29245201-8 2018 Postoperative levels of IL1-ss and IL-6 were lower in the allopurinol group. Allopurinol 58-69 interleukin 1 alpha Homo sapiens 24-27